Contact
Please use this form to send email to PR contact of this press release:
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
TO:
Please use this form to send email to PR contact of this press release:
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
TO: